Triple-dose regimen may permanently clear HIV in infected newborns

Researchers at Oregon Health & Science University have identified a potential one-time treatment regimen that could permanently clear HIV in newborns. The study, published in Nature Microbiology, suggests that combining neutralizing antibodies with antiretroviral therapy and leronlimab may be effective.